Haemolytic paroxysmal nocturnal haemoglobinuria in patients with myeloid neoplasms: A rare association with specific therapeutic implications
Aurélien Sutra Del Galy(Assistance Publique – Hôpitaux de Paris), Régis Peffault de Latour(Hôpital Saint-Louis), Maud D’Aveni(Centre Hospitalier Régional et Universitaire de Nancy), Benjamin Carpentier, Fiorenza Barraco(Hôpital Lyon Sud), Cécile Pautas(Centre Hospitalier Universitaire Henri-Mondor), Réda Garidi(Centre Hospitalier de Saint-Quentin), Flore Sicre de Fontbrune(Assistance Publique – Hôpitaux de Paris), Édouard Forcade(Hôpital Cardiologique du Haut-Lévêque), Lise Willems(Hôpital Cochin), Anne Banos(Centre Hospitalier de la Côte Basque), Sylvain Chantepie(Centre Hospitalier Universitaire de Caen Normandie)
Cited by 0
Related Papers
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials
|Journal of Clinical Oncology|2003|606
Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition
|Blood|2015|383